While the document does not introduce any new restrictions, it offers valuable insight into the substances that may face future regulatory action.
What is the REACH Restrictions Roadmap?
The REACH Restrictions Roadmap is a planning tool developed by the European Commission to improve transparency around the restriction process. It identifies substances and substance groups that are being evaluated for possible restrictions and shows where they are within the regulatory pipeline.
The roadmap allows companies to follow the progress of substances from the early stages of assessment through scientific evaluation and, where applicable, towards the adoption of formal restrictions. By making this information publicly available, the Commission aims to give industry more time to anticipate upcoming regulatory developments.
Does the updated roadmap introduce new legal requirements?
No. The Rolling List itself has no legal effect and does not prohibit or restrict the use of any substances.
Instead, it provides an indication of which chemicals are receiving regulatory attention. Some substances are in the early stages of data gathering, while others are progressing through the formal restriction procedure carried out under REACH. A substance appearing on the list may eventually become subject to a restriction, but this is not guaranteed.
For manufacturers, the document should therefore be viewed as an early-warning mechanism rather than a source of new compliance obligations.
How substances move through the restriction process
The restriction procedure under REACH involves several stages before any legal measures are adopted.
Potential restrictions are first prepared through the development of a restriction dossier. The proposal is then evaluated by the European Chemicals Agency (ECHA), including scientific assessments by its Committee for Risk Assessment (RAC) and Committee for Socio-economic Analysis (SEAC). Following these evaluations, the European Commission and the Member States decide whether a restriction should be introduced and how it should be implemented.
The updated roadmap helps stakeholders understand where individual substances currently stand within this process, allowing businesses to monitor developments well in advance.
Impact for the cosmetic industry
Although the roadmap applies to chemicals across many industrial sectors, it is particularly relevant for cosmetic manufacturers because many cosmetic ingredients are also regulated under REACH.
Substances used as solvents, preservatives, fragrance ingredients, processing aids, plasticisers or components of packaging materials may eventually become candidates for restriction. Companies that monitor the roadmap can identify potential risks earlier, assess alternative ingredients where appropriate and reduce the likelihood of supply chain disruptions.
This is especially important for businesses that develop new formulations, source ingredients globally or supply products throughout the European market.
Supporting the EU’s Chemicals Strategy for Sustainability
The updated roadmap also supports the objectives of the Chemicals Strategy for Sustainability, one of the key initiatives under the European Green Deal. The strategy aims to strengthen the protection of human health and the environment while encouraging the development and use of safer, more sustainable chemicals.
Increasing transparency around future restrictions is one way the European Commission hopes to make the EU chemicals regulatory framework more predictable for both regulators and industry.
Looking ahead
The revised REACH Restrictions Roadmap does not change the current legal status of any substance, but it provides valuable insight into where future regulatory action may occur. For cosmetic manufacturers and other companies using chemical raw materials, regularly reviewing updates to the Rolling List can support long-term product development, ingredient selection and regulatory planning.
As the European Commission continues to advance the Chemicals Strategy for Sustainability, early awareness of substances under evaluation will become increasingly important for maintaining compliance and reducing the impact of future regulatory changes.
